Table 3.
Relationship between Ecd expression and other biomarkers
| Parameter | Ecd expression | Significance | ||
|---|---|---|---|---|
| Low Ecd | High Ecd | Total | P value | |
| No. (%) | No. (%) | No. (%) | ||
| ERα status | ||||
| Negative | 47 (22.3) | 206 (28.6) | 253 (27.1) | 0.070 |
| Positive | 164 (77.7) | 515 (71.4) | 679 (72.9) | |
| Total | 211 | 721 | 932 | |
| PgR status | ||||
| Negative | 78 (38) | 303 (42.9) | 381 (41.8) | 0.213 |
| Positive | 127 (62) | 403 (57.1) | 530 (58.2) | |
| Total | 205 | 706 | 911 | |
| HER-2 status | ||||
| Negative | 191 (92.3) | 612 (84) | 803 (85.8) | 0.002 |
| Positive | 16 (7.7) | 117 (16) | 133 (14.2) | |
| Total | 207 | 729 | 936 | |
| ER.PR. status | ||||
| ER-PR- | 44 (21.8) | 197 (28.5) | 241 (27) | 0.29 |
| ER-PR+ | 1 (0.5) | 2 (0.3) | 3 (0.3) | |
| ER + PR- | 31 (15.3) | 95 (13.7) | 126 (14.1) | |
| ER + PR+ | 126 (62.4) | 397 (57.5) | 523 (58.6) | |
| Total | 202 | 691 | 893 | |
| Triple negative status | ||||
| Non-TN | 172 (82.3) | 587 (81.4) | 759 (81.6) | 0.772 |
| TN | 37 (17.7) | 134 (18.6) | 171 (18.4) | |
| Total | 209 | 721 | 930 | |
| Basal type | ||||
| Negative | 153 (73.6) | 559 (80.3) | 712 (78.8) | 0.037 |
| Positive | 55 (26.4) | 137 (19.7) | 192 (21.2) | |
| Total | 208 | 696 | 904 | |
| p53 | ||||
| Negative | 154 (75.1) | 494 (71.1) | 648 (72) | 0.257 |
| Positive | 51 (24.9) | 201 (28.8) | 252 (28) | |
| Total | 205 | 695 | 900 | |
| Ki67 | ||||
| Moderate | 145 (79.2) | 455 (75.8) | 600 (76.6) | 0.341 |
| High | 38 (20.8) | 145 (24.2) | 183 (23.4) | |
| Total | 183 | 600 | 783 | |